Don't get left behind! The modernized is coming. Check it out now.
Say goodbye to!
The new site is coming soon - go to the modernized
Working… Menu

Neihulizumab for Standard-Risk Acute Graft Versus Host Disease (GVHD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04144036
Recruitment Status : Recruiting
First Posted : October 30, 2019
Last Update Posted : February 17, 2023
Information provided by (Responsible Party):
Sameem M. Abedin, MD, Medical College of Wisconsin

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 1, 2023
Estimated Study Completion Date : November 30, 2024